Clik here to view.
Is Sleeping With Your Baby a Good Idea? Here’s What the Science Says
Gabrielle Fréchette-Boilard, Université du Québec à Trois-Rivières (UQTR) and Evelyne Touchette, Université du Québec à Trois-Rivières (UQTR) Sleeping with your baby is not life-threatening, but it’s...
View ArticleSurge in Overheating Reports Triggers FDA Alert on Philips DreamStation 2
The US Food and Drug Administration (FDA) is warning patients and health care providers to carefully monitor Philips DreamStation 2 continuous positive airway pressure (CPAP) machines for signs of...
View ArticleThe Bilevel Blunder
Sleep specialists prescribe bilevel PAP in hopes of increased efficacy and adherence in patients who don’t tolerate CPAP well. But could it instead be exacerbating therapy problems in some obstructive...
View ArticleChinstrap Penguins Meet Sleep Needs in Four-Second Bursts
In the wild, nesting chinstrap penguins get more than 11 hours of sleep per day—but not all at once, according to a new study. The study, published in Science, found that these birds nod off...
View ArticleJazz Pauses Orexin Agonist Trial After Reports of ‘Visual Disturbances’
Jazz Pharmaceuticals is pausing its phase 1 clinical trial investigating JZP441, an oral orexin-2 receptor agonist with potential application for the treatment of narcolepsy and other sleep disorders,...
View ArticleSleep-Like Brain Waves Detected in Awake Epilepsy Patients May Be Protective
Slow waves that usually only occur in the brain during sleep are also present during wakefulness in people with epilepsy and may protect against increased brain excitability associated with the...
View ArticleRising Health Challenges Fuel Japan’s Sleep Apnea Market, Data Firm Finds
Owing to increasing occurrences of stress and depression, obesity, long working hours, and high incidences of diabetes, Japan’s market for sleep apnea diagnostic equipment is expected to reach $100...
View ArticleFDA Clears First Oral Appliances to Treat Severe OSA
By Alyx Arnett Vivos Therapeutics has received 510(k) clearance from the US Food and Drug Administration (FDA) for treating moderate to severe obstructive sleep apnea (OSA) in adults using the Vivos’...
View ArticleOne Sleepless Night Diminishes Decision-Making Abilities
New research reveals that just one night without sleep can significantly alter decision-making processes. The power of sleep and the vital role it plays in human health, cognitive performance, and...
View ArticleGenetics and Mental Health May Influence Sleep Medication Use
A genetic study involving almost 800,000 participants has uncovered genetic factors that contribute to the use of sleep medications, shedding new light on the intricate relationship between sleep...
View ArticleClik here to view.
Disposable HST Manufacturers Talk Tech, Accuracy, Updates, and Potential
Insights from disposable home sleep test experts at Sunrise, SleepImage, and ZOLL Itamar about technological advancements, new features, and other aspects of the present and future of sleep testing....
View ArticleFDA Clears Forehead-Worn Home Sleep Test
Australia-based Compumedics announced the US Food and Drug Administration (FDA) has cleared the Somfit device—an adhesive device worn on a patient’s forehead to collect physiological data, used...
View ArticleEast-West Travel Negatively Impacts Student-Athletes’ Health Through Sleep...
Announcements in June 2022 of possible realignments of major east-west athletic conferences raised concern among many sleep and circadian physicians and scientists across the United States. As a...
View ArticleNew Clinician Guidance for Down Syndrome to Include Sleep Apnea Section
The Global Down Syndrome Foundation announced the roster of authors for the second edition of the first evidence-based GLOBAL Medical Care Guidelines for Adults with Down Syndrome, which will include...
View ArticleNLS Pharmaceutics Acquires Rights to Aexon Labs’ Orexin Agonists
Swiss clinical-stage biopharmaceutical company NLS Pharmaceutics Ltd has entered into an exclusive option agreement with Aexon Labs Inc, a privately held US company, to develop and commercialize Aexon...
View ArticleEPAP-Enhanced Oral Appliance Study Wins CHEST 2023 Top Abstract Award
A clinical trial demonstrating the efficacy of the ExVent accessory with the O2Vent Optima oral appliance for the treatment of obstructive sleep apnea (OSA) was awarded the Top Abstract Poster Award...
View ArticleSleep Problems Linked to Heart Health Risks During and After Menopause
How well a woman sleeps—not just how long—as she transitions through menopause may affect her projected risk for heart disease and stroke, new research suggests. The study found women who were peri-...
View ArticleSleep Consistency in Midlife May Prevent Cognitive Decline in Later Years
Older adults whose sleep duration varied over a two-decade-long study were much more likely to develop cognitive decline compared with those whose sleep duration did not vary significantly, new...
View ArticleMajority of Americans Sacrifice Sleep for Screens
A recent survey reveals that the majority of Americans are losing sleep to digital distractions, prompting sleep experts to call for healthier bedtime habits. The survey from the American Academy of...
View ArticleRhinAer for Chronic Rhinitis Still Effective After Two Years, Study Finds
A recent clinical trial has shown that patients with chronic rhinitis experienced sustained symptom relief and improved quality of life for up to two years following treatment with RhinAer, a...
View Article
